Summary:
A double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with Bipolar Depression.
Qualified Participants Must:
• Be suffering from Bipolar Depression
•
Be between 18 and 65 years of age
•
Have a body mass index between 18 and 40
Qualified Participants May Receive:
Investigational medication, stipend for time and travel, free follow-up care after study is completed.